Close
Show
Home News Page 3

News

This section brings in the latest news and the headlines in the Pharmaceutical industry. Our dedicated news team closely observes the Pharma Industry and keeps you updated of latest developments across the world.

FDA Rebukes Althera For Its Cholesterol Medication Claims

FDA Rebukes Althera For Its Cholesterol Medication Claims


Althera Pharmaceuticals, a producer of cardiovascular drugs, is being investigated by the FDA for its...

The North Carolina Seqirus Factory Gets A $156mn Upgrade


Seqirus recently completed a $156 million expansion plan at its Holly Springs, North Carolina, fill-finish...
GARDP And Bugworks Evaluate The New Antibiotic Tolerability

GARDP And Bugworks Evaluate The New Antibiotic Tolerability


The Global Antibiotic Research and Development Partnership- GARDP and Bugworks are working together on research to determine...
GSK Unveils New Logo, Branding To Mirror Improved Business

GSK Unveils New Logo, Branding To Mirror Improved Business


The British Big Pharma has launched an innovative rebranding, a tech-flavoured logo, and an impactful...
Amarin Wins Vazkepa In U.K Days After US Downsizing Plan

Amarin Wins Vazkepa In U.K Days After US Downsizing Plan


Amarin has earned a much-needed triumph internationally after faltering in the crucial US market. Vazkepa...
Teva Drives Positive Impact in Response to COVID-19 Pandemic

Teva Post Lupin Deal To Launch Austedo Generic Rival In 2033


Teva can rest easy knowing that it does have a long runway free of generics—at...
Astellas Announces Construction of New Manufacturing Facility for Active Pharmaceutical Ingredient of Prograf

Fibrogen-Astellas Anaemia Drug Evrenzo Gets NICE Backing


Despite a high-profile FDA denial, FibroGen and its collaborators have been able to expand into...
For Stakeholders Bidens Bid To Cut Drug Costs Is A Top Issue

Drug Launch Prices Have Gone Up 20% Yearly For A Decade


As many Americans face difficult financial decisions thanks to inflation, a new study verifies what...

FDA Advisory Group Permits Bluebird Gene Therapy Amid Risks


Bluebird bio has persuaded an expert committee that the benefits of its gene therapy possibility,...
Alnylam Pharmaceuticals partners with Sharp on packaging RNA interference (RNAi) therapeutics for Europe

Alnylam Shares Findings On Delivering siRNA Beyond The Liver


Alnylam has outlined their strategy for delivering siRNA to the central nervous system and other...